ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Amyloidosis"

  • Abstract Number: 246 • 2016 ACR/ARHP Annual Meeting

    Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis

    Bahtiyar Toz1, Seher Tecer2, Emin Oğuz1, Murat Erdugan1, Bahar Artim-Esen1, Sevil Kamali3, Murat Inanc4, Lale Ocal3, Burak Erer1 and Ahmet Gul1, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Istanbul faculty of medicine Istanbul University, Istanbul, Turkey, 3Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 4Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey

    Background/Purpose: Familial Mediterranean fever (FMF), the most common form of hereditary autoinflammatory diseases, is associated with increased risk for secondary (AA) amyloidosis. We herein aimed…
  • Abstract Number: 943 • 2016 ACR/ARHP Annual Meeting

    Efficacy and Safety of IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever Who Underwent Kidney Transplantation

    Bahtiyar Toz1, Yaşar Kerem Çalışkan2, Burak Erer1, Lale Ocal3 and Ahmet Gul1, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Division of Nephrology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey, 3Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease characterized by self-limiting febrile attacks associated with serosal or synovial inflammation as well as increased…
  • Abstract Number: 1581 • 2015 ACR/ARHP Annual Meeting

    Cardiac Involvement in Patients with Amyloid a Amyloidosis Due to Rheumatoid Arthritis

    Daisuke Kobayashi1, Satoshi Ito1, Yoko Wada2, Akira Murasawa1, Ichiei Narita2 and Kiyoshi Nakazono1, 1Niigata Rheumatic Center, Shibata, Japan, 2Department of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is one of the major causes of amyloid A (AA) amyloidosis, the major organs affected being the kidneys and gastrointestinal (GI)…
  • Abstract Number: 260 • 2015 ACR/ARHP Annual Meeting

    Tocilizumab Is Effective in the Treatment of AA Amyloidosis Secondary to Familial Mediterranean Fever

    Huri Ozdogan1, Serdal Ugurlu2, Aysa Hacioglu2, Yasaman Adibnia2 and Vedat Hamuryudan2, 1Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 2Rheumatology, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

    Background/Purpose: AA amyloidosis is the long-term complication of various chronic inflammatory diseases avoidable by the treatment of the underlying disease but with no established treatment…
  • Abstract Number: 2523 • 2014 ACR/ARHP Annual Meeting

    Are Biologic Agents Effective on the Treatment of Secondary Amyloidosis: A Multicenter Report on Turkish Rheumatoid Arthritis and Ankylosing Spondylitis Patients

    Omer Nuri Pamuk1, Umut Kalyoncu2, Kenan Aksu3, Salim Donmez4, Yavuz Pehlivan5, Yonca Cagatay6, Ahmet Omma7, Orhan Küçükşahin8, Gozde Yildirim Cetin9, Özün Bayındır10, Fatih Yildiz11, Ayse Balkarli12, Levent Kilic13, Necati Cakir14, Bunyamin Kisacik15, Ahmet Mesut Onat15, Mustafa Ferhat Özgür16, Veli Cobankara12 and Mehmet Sayarlioglu17, 1Rheumatology, Trakya University Medical Faculty, Edirne, Turkey, 2Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey, 3Rheumatology, Ege University School of Medicine, Izmir, Turkey, 4Department of Rheumatology, Trakya University School of Medicine, Edirne, Turkey, 5Rheumatology, Uludag University, School of Medicine, Bursa, Turkey, 6Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, 7ROMATOLOJI SERVISI, IST. UNV. TIP FAK. HASTANESI, ISTANBUL, Turkey, 8Trakya University Medical Faculty, İstanbul, Turkey, 9Ismet Pasa Mah, None, Kahramanmaras, Turkey, 10Ege University Medical Faculty, Izmir, Turkey, 11Rheumatology, Cukurova University, School of Medicine, Adana, Turkey, 12Department of Rheumatology, Pamukkale University School of Medicine, Denizli, Turkey, 13Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 14Fatih Sultan Mehmet State Hospital, İstanbul, Turkey, 15Rheumatology, Gaziantep University School of Medicine, Gaziantep, Turkey, 16Uludag University Medical Faculty, Bursa, Turkey, 17Rheumatology, KahramanmarasSutçü ImamUniversity School of Medicine, Kahramanmaras, Turkey

    Background/Purpose Biologic drugs including anti-TNF agents have been used in the treatment of secondary amyloidosis, however, there is no controlled study concerning the efficacy of…
  • Abstract Number: 1416 • 2014 ACR/ARHP Annual Meeting

    Analysis of Cardiac Involvement in Patients with Amyloid a (AA) Amyloidosis Due to Rheumatoidarthritis

    Daisuke Kobayashi1, Satoshi Ito1, Satoru Kodama1, Akira Murasawa1, Ichiei Narita2 and Kiyoshi Nakazono1, 1Niigata Rheumatic Center, Shibata, Japan, 2Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

    Background/Purpose Rheumatoid arthritis (RA) is one of the major causes of amyloid A (AA) amyloidosis. The major organs affected are the kidneys and gastrointestinal (GI)…
  • Abstract Number: 1233 • 2014 ACR/ARHP Annual Meeting

    Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever

    Huri Ozdogan, Serdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia and Vedat Hamuryudan, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

    Background/Purpose: AA amyloidosis is the major long-term complication of various chronic inflammatory diseases like rheumatoid arthritis, ankylosing spondylitis, FMF and other autoinflammatory syndromes. Treatment of…
  • Abstract Number: 568 • 2014 ACR/ARHP Annual Meeting

    Secondary Amyloidosis Complicating Spondyloarthritis: Still Present after All These Years

    Samantha Rodriguez-Muguruza1, Melania Martínez-Morillo1, Susana Holgado1, Maria Lourdes Mateo1, Juana Sanint1, Anne Riveros-Frutos2, Jeronima Cañellas1, Xavier Tena1 and Alejandro Olivé Marqués1, 1Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, 2Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain

    Background/Purpose: Secondary amyloidosis (AA) is a disorder caused by deposition of insoluble amyloid A fibrils in different tissues and organs. It is a rare and…
  • Abstract Number: 2389 • 2013 ACR/ARHP Annual Meeting

    Tocilizumab Survives Introducing The Hemadialysis Longer Than Oral Medicine In AA Amyloidosis Patients With Rheumatoid Arthritis Of Renal Insufficiency

    Osamu Saiki1, Hiroshi Uda1, Ayumi Matsumoto2, Aya Mizumoto3, Tamaki Harada3 and Toshirou Takama3, 1Rheumatology, Higashiosaka City General Hospital, Higashiosaka, Japan, 2Higashiosaka City General Hospital, Higashiosaka, Japan, 3Nephrology, Higashiosaka City General Hospital, Higashiosaka, Japan

    Background/Purpose: In AA amyloidosis patients with RA taking oral medicines such as methotrexate and prednisolone, it is generally accepted that the renal function deteriorates gradually…
  • Abstract Number: 1659 • 2013 ACR/ARHP Annual Meeting

    Systematic Review Of Amyloid Beta-Related Angiitis: A Treatable Cause Of Vasculitis Affecting Central Nervous System

    Abhijeet Danve1 and Atul A. Deodhar2, 1Rheumatology, Oregon Health and Science University, Portland, OR, 2Oregon Health and Science University, Portland, OR

    Background/Purpose: Amyloid β-related angiitis (ABRA) is a rare type of Central Nervous System Vasculitis (CNSV), which complicates Cerebral Amyloid Angiopathy (CAA).  Data about clinical features,…
  • Abstract Number: 2387 • 2013 ACR/ARHP Annual Meeting

    Change of serum Amyloid a predict The Effect Of Biological Treatment In Rheumatoid Arthritis Patient

    Chisa Okura1, Yukio Yonemoto2, Koichi Okamura1, Tetsuya Kaneko3, Tsutomu Kobayashi1 and Kenji Takagishi1, 1Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan, 2Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan, 3Department of Orthopaedic Surgery, Inoue Hospital, Takasaki, Gunma, Japan

    Background/Purpose: The C-reactive protein (CRP) level and the erythrocyte sedimentation rate (ESR) are common markers of inflammation in patients with rheumatoid arthritis (RA). The serum…
  • Abstract Number: 194 • 2012 ACR/ARHP Annual Meeting

    LONG-TERM Efficacy of Tocilizumab in A Patient with Amyloidosis and Interstitial Pneumonia Secondary to Multicentric Castleman’s Disease (MCD)

    Michihito Katayama1, Soichiro Tsuji1, Satoshi Teshigawara1, Eriko Kudo-Tanaka1, Maiko Yoshimura1, Akane Watanabe1, Akiko Yura2, Yoshinori Harada3, Yoshinori Katada3, Jun Hashimoto1, Masato Matsushita4, Yukihiko Saeki5 and Shiro Ohshima5, 1Dept of Rheumatology, Osaka-Minami Medical Center, Kawachinagano City, Japan, 2Dept of Allergology, Allergology,Osaka-Minami Medical Center, Kawachinagano City, Japan, 3Dept of Allergology, Kawachinagano City, Japan, 4Rheumatology, Osaka Minami Medical Center, Osaka, Japan, 5Dept of Clinical Research, Osaka-Minami Medical Center, Kawachinagano City, Japan

    Background/Purpose: Castleman’s disease is a benign lymphoproliferative disorder characterized histologically by follicular hyperplasia and capillary proliferation with endothelial hyperplasia. In addition, overproduction of Interleukin-6 (IL-6)…
  • Abstract Number: 747 • 2012 ACR/ARHP Annual Meeting

    Familial Mediterranean Fever: Inhibition of IL-6 Signalling As a New Therapeutic Option in a Frequent Autoinflammatory Syndrome.

    Nicola Stein1, Matthias Witt2, Michael Baeuerle3, Fabian Proft1, Hendrik Schulze-Koops4 and Mathias Gruenke1, 1Rheumaeinheit, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany, 2Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, 3Division of Rheumatology, Klinikum Nürnberg, Nuernberg, Germany, 4University of Munich, Munich, Germany

    Background/Purpose: Familial Mediterranean Fever (FMF) is the most prevalent episodic fever syndrome with more than 100.000 affected individuals worldwide. Colchicine is the established first-line therapy…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2018 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies